These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6972939)

  • 1. Izumenolide-a novel beta-lactamase inhibitor produced by Micromonospora. II. Biological properties.
    Bush K; Bonner DP; Sykes RB
    J Antibiot (Tokyo); 1980 Nov; 33(11):1262-9. PubMed ID: 6972939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Izumenolide-a novel beta-lactamase inhibitor produced by Micromonospora. I. Detection, isolation and characterization.
    Liu WC; Astle G; Wells JS; Trejo WH; Principe PA; Rathnum ML; Parker WL; Kocy OR; Sykes RB
    J Antibiot (Tokyo); 1980 Nov; 33(11):1256-61. PubMed ID: 6972938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of beta-lactamase of Streptomyces cacaoi. II. CP-45,899, izumenolide and cephamycins.
    Mantoku A; Ogawara H
    J Antibiot (Tokyo); 1981 Oct; 34(10):1347-50. PubMed ID: 6273376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
    Chin NX; McElrath MJ; Neu HC
    Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening of beta-lactamase inhibitors among representatives of the genus Micromonospora and the genus Streptoverticillium].
    Bibikova MV; Ivanitskaia LP; Nikishina VG; Rybakova AM
    Antibiotiki; 1983 Sep; 28(9):665-71. PubMed ID: 6605711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tackling the Antibiotic Resistance Caused by Class A
    Eiamphungporn W; Schaduangrat N; Malik AA; Nantasenamat C
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of mycinamicin production by dotriacolide in Micromonospora griseorubida.
    Takenaka S; Yoshida K; Yamaguchi O; Shimizu K; Morohoshi T; Kinoshita K
    FEMS Microbiol Lett; 1998 Oct; 167(1):95-100. PubMed ID: 9841223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple method for testing the efficacy of a beta-lactamase inhibitor against beta-lactamase-producing gram-negative bacteria.
    Sawai T; Yoshida T
    J Antibiot (Tokyo); 1982 Aug; 35(8):1072-7. PubMed ID: 6982888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.
    Rotschafer JC; Ostergaard BE
    Am J Health Syst Pharm; 1995 Mar; 52(6 Suppl 2):S15-22. PubMed ID: 7606585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of beta-lactamase inhibitors].
    Hyodo A; Higashitani F; Nishida K; Kunugita C; Unemi N
    Nihon Rinsho; 1997 May; 55(5):1272-80. PubMed ID: 9155186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactamases, beta-lactamase inhibitors, and skin and skin-structure infections.
    Neu HC
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):896-904. PubMed ID: 2189913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiolactomycin, a new antibiotic. III. In vitro antibacterial activity.
    Noto T; Miyakawa S; Oishi H; Endo H; Okazaki H
    J Antibiot (Tokyo); 1982 Apr; 35(4):401-10. PubMed ID: 6980215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and beta-lactamase inhibitory activities of some clavulanic acid analogues.
    Mak CP; Prasad K; Turnowsky F
    J Antibiot (Tokyo); 1983 Apr; 36(4):398-406. PubMed ID: 6602120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors.
    Vedel G; Belaaouaj A; Gilly L; Labia R; Philippon A; Névot P; Paul G
    J Antimicrob Chemother; 1992 Oct; 30(4):449-62. PubMed ID: 1490918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dotriacolide, a new beta-lactamase inhibitor.
    Ikeda Y; Kando S; Sawa T; Tsuchiya M; Ikeda D; Hamada M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Dec; 34(12):1628-30. PubMed ID: 6977522
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative beta-lactamase resistance and inhibitory activity of 1-oxa cephalosporin, cefoxitin and cefotaxime.
    Fu KP; Neu HC
    J Antibiot (Tokyo); 1979 Sep; 32(9):909-14. PubMed ID: 315938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing of inhibitors against CTX-M-15 type β-lactamase: potential drug candidate against β-lactamases-producing multi-drug-resistant bacteria.
    Ali A; Danishuddin ; Maryam L; Srivastava G; Sharma A; Khan AU
    J Biomol Struct Dyn; 2018 May; 36(7):1806-1821. PubMed ID: 28545327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of M-GTFI, an inhibitor of glucosyltransferase from S. mutans, and its inhibitory relationship with other sulfate ester-containing inhibitors.
    Uyeda M; Oshima H; Nishi K; Suzuki K; Yahara S; Nohara T; Shibata M
    J Enzyme Inhib; 1989; 2(4):279-94. PubMed ID: 2542491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.